PDL BIOPHARMA, INC. (33) | Human Resources (9)
Browse by Subcategory
Recent Contracts
-
Transition Services Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc
(Filed With SEC on October 2, 2020)
-
Separation and Distribution Agreement, dated as of September 30, 2020, by and between PDL BioPharma, Inc
(Filed With SEC on October 2, 2020)
-
Confidential Severance Agreement and Release of All Claims
(Filed With SEC on August 20, 2020)
-
2020 Annual Bonus Plan
(Filed With SEC on May 11, 2020)
-
Wind Down Retention Plan effective as of December 21, 2019
(Filed With SEC on March 11, 2020)
-
Severance Plan adopted as of November 15, 2019
(Filed With SEC on March 11, 2020)
-
Confidential Severance Agreement and Release of All Claims
(Filed With SEC on August 19, 2019)
-
2019 Annual Bonus Plan
(Filed With SEC on May 9, 2019)
-
Executive Severance Plan and Schedule of Benefits
(Filed With SEC on April 10, 2019)